From Molecule to Market: An Educational Panel Series About Careers in Drug Development

Event details
Amgen, the Association for Women in Science and the Healthcare Businesswomen's Association are proud to present "From Molecule to Market: An Educational Panel Series About Careers in Drug Development." This three-part panel series will feature industry experts sharing career advice from various stages of the pharmaceutical development process, from early discovery and process development to clinical research, regulatory and marketing. The goal of each panel is to provide our audience with an understanding of the drug development process, the roles and responsibilities of the functions involved and offer advice from industry experts on what it takes to be successful in these roles. We hope this event will help early and mid-career women to expand their horizons, make informed career decisions and be inspired to achieve the next level professionally. The event will include a moderated panel discussion followed by an interactive Q & A with the audience.

The panel series kicks off on November 5 at Amgen with a focus on the early stages of drug development process: discovery, research, toxicology and early process development.

The panel will be moderated by Mary Ellen Cosenza, PhD (executive director of U.S. regulatory, Amgen, Inc.)

Featured panelists include:

•   Cindy Afshari, PhD, DABT (Executive director, toxicology, Amgen, Inc.)
•   Ingrid Joseph, DVM, PhD (Senior director of pharmacology and bioimaging, Agensys, Inc.)
•   Jennifer Lafontaine (Director of cancer platform chemistry, Pfizer, Inc. La Jolla)
•   Karen Miller, PhD (Director, early process development, Amgen, Inc.)

Students and non-members are welcome. Heavy appetizers and beverages will be provided. We look forward to seeing you at the event.

Learning objectives
1. Provide a better understanding of the early drug development process (discovery, research, toxicology and early process development)
2. Introduce industry experts and ' career development experiences and lessons learned
3. Better understand the roles and responsibilities of the functions involved during the drug development process

Agenda
6:00 PM - 7:00 PM   Registration and networking reception
7:00 PM - 8:30 PM   Moderated panel discussion and Q & A
8:30 PM - 9:00 PM   Wrap-up/additional networking/adjourn

Event location
Amgen
One Amgen Center Drive
Thousand Oaks, CA 91320
805.447.1000

Directions

Sponsors





Speakers
Mary Ellen Cosenza, PhD (Moderator)
Executive director, US regulatory, Amgen, Inc.

Cindy Afshari, PhD, DABT
Executive director, toxicology, Amgen, Inc.

Ingrid Joseph, DVM., PhD
Senior director of pharmacology and bioimaging, Agensys, Inc.

Jennifer LaFontaine
Director of cancer platform chemistry, Pfizer, Inc. La Jolla

Karen Miller, PhD
Director, early process development, Amgen, Inc.

Registration information
Event is open to: HBA/AWIS members and nonmembers
Online Registration deadline: November 4, 2014
Onsite (walk-in) registration: Is allowed

Member rate:
$30 until October 28, 2014
$40 after October 28, 2014

Nonmember rate:
$50 until October 28, 2014
$60 after October 28, 2014

Student rate:
$30 until October 28, 2014
$45 after October 28, 2014

AWIN/AWIS rate:
$30 until October 28, 2014
$40 after October 28, 2014

Capacity
Is capacity limited? Yes
Space is limited to 300 registrants.

Cancellations/refunds
Is this event refundable? Yes
If yes, must be submitted in writing to events@hbanet.org by October 28, 2014; no refunds are available after this date.

Event questions/support
- Program contact for event details: Email marcia.g.beymer@gmail.com and/or call 602-819-7012
- Membership questions: membership@hbanet.org or 973-575-0606 ext 1
- Trouble with online registration: events@hbanet.org or 973-575-0606 ext 3

Visit us online

Pricing

	Member	Non-Member
AWIN/AWIS Registration	$40.00 / €34.00	$40.00 / €34.00
Regular Registration	$40.00 / €34.00	$60.00 / €51.00
Student Registration	$45.00 / €39.00	$45.00 / €39.00

Members receive up to 50 percent discount

Event Policies

Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.

COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.

By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.

Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.